瘧疾診斷市場規模、佔有率和成長分析（按產品、技術、最終用途和地區）- 產業預測（2025-2032 年）

2023 年全球瘧疾診斷市場規模為 8.4451 億美元，預計將從 2024 年的 8.842 億美元成長到 2032 年的 12.7681 億美元，預測期內（2025-2032 年）的複合年成長率為 4.7%。

受分子診斷和快速診斷測試 (RDT) 等診斷技術的進步推動，全球瘧疾診斷市場正在經歷顯著成長。這些創新提高了敏感性、特異性和易用性，從而能夠快速診斷，特別是在資源有限的地區。人們對早期發現瘧疾的認知不斷提高，再加上政府措施和全球基金等組織的支持，進一步推動了市場的擴張。但挑戰依然存在，包括偏遠地區衛生基礎設施不足，以及對低收入國家檢測的可負擔性和可近性的擔憂。此外，一些測試的準確性問題和監管障礙也可能限制成長。為了有效對抗瘧疾，公私合作對於開發經濟實惠、可靠且適合當地文化的診斷解決方案至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

瘧疾診斷市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 裝置
• 套件和試劑

瘧疾診斷市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 顯微鏡
• 快速診斷測試
• 分子診斷檢測
  • 常規 PCR
  • 即時PCR
• 其他技術

瘧疾診斷市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 診所
• 醫院
• 診斷中心
• 其他

瘧疾診斷市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• 雅培實驗室（美國）
• Bio-Rad Laboratories, Inc.（美國）
• 西門子醫療股份公司（德國）
• 賽默飛世爾科技公司（美國）
• F. Hoffmann-La Roche Ltd（瑞士）
• 生物梅里埃公司（法國）
• 貝克曼庫爾特公司（美國）
• Cepheid Inc.（美國）
• 丹納赫集團（美國）
• Hologic 公司（美國）
• Illumina公司（美國）
• Qiagen NV（荷蘭）
• Sysmex 公司 (日本)
• 尼康公司（日本）
• 奧林巴斯株式會社（日本）
• DiaSorin SpA（義大利）
• Trinity Biotech plc（愛爾蘭）
• 富士軟片株式會社（日本）

結論和建議

Global Malaria Diagnostics Market size was valued at USD 844.51 million in 2023 and is poised to grow from USD 884.2 million in 2024 to USD 1276.81 million by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).

The global malaria diagnostics market has experienced significant growth, propelled by advancements in diagnostic technologies like molecular diagnostics and rapid diagnostic tests (RDTs). These innovations have enhanced sensitivity, specificity, and user-friendliness, enabling quicker diagnoses, particularly in resource-limited areas. Increasing awareness of early malaria detection, coupled with government initiatives and support from organizations like the Global Fund, has further stimulated market expansion. However, challenges persist, including inadequate healthcare infrastructure in remote regions, as well as concerns about the affordability and accessibility of tests in low-income countries. Additionally, issues regarding the accuracy of some tests and regulatory obstacles may limit growth. Collaborative efforts from public and private sectors are essential to develop affordable, reliable, and culturally appropriate diagnostic solutions to combat malaria effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Malaria Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Malaria Diagnostics Market Segments Analysis

Global Malaria Diagnostics Market is segmented by Product, Technology, End-use and Region. Based on Product, the market is segmented into Instruments and Kits & reagents. Based on Technology, the market is segmented into Microscopy, Rapid diagnostic tests, Molecular diagnostic tests and Other technologies. Based on End-use, the market is segmented into Clinics, Hospitals, Diagnostic centers and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is significantly influenced by regions heavily impacted by malaria, especially in sub-Saharan Africa and certain areas of Asia. In these regions, there is a strong demand for effective malaria diagnostics driven by the critical need for accurate and prompt diagnosis. Timely identification of malaria cases is essential for the effective management and control of the disease, making malaria diagnostics an indispensable part of public health efforts. As the burden of malaria remains high, the focus on developing and implementing reliable diagnostic tools will continue to be a major driver for the market's growth and evolution.

Restraints in the Global Malaria Diagnostics Market

The global malaria diagnostics market faces significant restraints due to inadequate investment in research and development. This shortfall restricts the emergence of innovative and advanced diagnostic technologies, as there is insufficient funding for research initiatives aimed at creating tests that are more sensitive, specific, and cost-effective. Consequently, the lack of financial support hampers progress in developing better diagnostic solutions, potentially stalling efforts to enhance malaria detection and management. Without increased investment in R&D, the market may struggle to keep pace with the evolving needs for effective malaria diagnostics, ultimately impacting control and prevention strategies globally.

Market Trends of the Global Malaria Diagnostics Market

The Global Malaria Diagnostics market is witnessing significant growth, particularly driven by expansion into emerging markets across Asia, Latin America, and Africa. As healthcare expenditures rise alongside heightened awareness of infectious diseases, these regions are becoming hotspots for diagnostic innovation. Government initiatives aimed at combating malaria further bolster this trend, creating a favorable environment for diagnostic companies. To effectively tap into these burgeoning markets, businesses are focusing on developing cost-effective and culturally sensitive diagnostic solutions that cater to local needs, ultimately enhancing accessibility and improving health outcomes in malaria-endemic regions. This strategic focus is poised to accelerate market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Malaria Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits & reagents

Global Malaria Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Microscopy
• Rapid diagnostic tests
• Molecular diagnostic tests
  • Conventional PCR
  • Real-time PCR
• Other technologies

Global Malaria Diagnostics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Clinics
• Hospitals
• Diagnostic centers
• Other end-users

Global Malaria Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-use)
  • US
  • Canada
• Europe (Product, Technology, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen NV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FujiFilm Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations